Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer

36Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to identify the appropriate DNA sequence and design high-quality primers for methylation-specific polymerase chain reaction (MSP). These primers may be used to examine and identify patients with early-stage epithelial ovarian carcinoma (EOC). Opioid binding protein/cell adhesion molecule like (OPCML), Runt-related transcription factor 3 and tissue factor pathway inhibitor 2 were selected as possible molecular markers. MSP primer sets were designed to monitor the methylation of the three markers. Free circulating DNA (fcDNA) from 194 patients with epithelial ovarian carcinoma and healthy donors were templates in the nested MSP. OPCML MSP was effective with respect to screening methylated fcDNA. One-way ANOVA P-values indicated that the difference in cancer antigen 125 (CA125), a biomarker for EOC diagnosis, level between early EOC and healthy donors was not significant. The methylation of OPCML was significantly altered in early-stage EOC compared with healthy donors (P<0.0001), and this supported the hypothesis that specific fcDNA methylation was able to distinguish patients with early-stage EOC from healthy donors. With respect to detecting early EOC, compared with the results of the CA125 test, MSP increased the κ coefficient from 0.140 to 0.757. Therefore, OPCML combined with fcDNA may be used to establish an improved clinical assay compared with the current CA125 test.

References Powered by Scopus

Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands

5334Citations
N/AReaders
Get full text

CpG islands and the regulation of transcription

2386Citations
N/AReaders
Get full text

MethPrimer: Designing primers for methylation PCRs

2210Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?

128Citations
N/AReaders
Get full text

Potential clinical utility of liquid biopsies in ovarian cancer

80Citations
N/AReaders
Get full text

Perspectives on liquid biopsy for label-free detection of “circulating tumor cells” through intelligent lab-on-chips

74Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wang, B., Yu, L., Luo, X., Huang, L., Li, Q. S., Shao, X. S., … Yang, G. Z. (2017). Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer. Oncology Letters, 14(1), 217–223. https://doi.org/10.3892/ol.2017.6111

Readers over time

‘17‘18‘19‘20‘21‘22‘23‘24‘2502468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

65%

Researcher 4

24%

Professor / Associate Prof. 1

6%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

53%

Biochemistry, Genetics and Molecular Bi... 3

20%

Computer Science 2

13%

Chemistry 2

13%

Save time finding and organizing research with Mendeley

Sign up for free
0